Abramson JS, Solomon SR, Arnason JE, Johnston PB, et al. Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of phase 3 TRANSFORM study. Blood 2022 Dec 21:blood.2022018730. doi: 10.1182/blood.2022018730.
PMID: 36542826